Science & Technology
- Written by President’s Spokesperson
President Reuven Rivlin today (Thursday), was presented at his residence with a special issue of the renowned medical journal, The Lancet, dedicated to Israel’s healthcare system and medical innovations in Israel. The President received the special publication from Lancet Editor-in-Chief, Dr. Richard Horton. The meeting was also attended by senior medical figures and researchers who had contributed to the publication.
- Written by The Hebrew University of Jerusalem
Jerusalem, April 5, 2017 — The Hebrew University of Jerusalem has announced the launch of a Multidisciplinary Center on Cannabinoid Research (http://cannabinoids.huji.ac.il). The new Center will serve as one of the world’s leading institutes for conducting and coordinating research about cannabinoids, endocannabinoids and medicalCannabis. In addition, it will promote collaboration and disseminate information.
Staffed by some of the world’s leading scientists and medical doctors from the Hebrew University and its affiliated Hadassah Medical Center, the Multidisciplinary Center is already supporting exciting new research. In February 2017, the Center awarded funding to three research projects:
—The effects of CBD on traumatic brain injury (Prof. Rami Yaka & Prof. Oren Ostresetzer)
—The anti-angiogenic and anti-cancer activity of cannabinoid receptor 2 (CB2) agonists (Dr. Ofra Benny)
—Effect of a Cannabis extract on acute radicular pain and on analgesics (Prof. Elyad Davidson)
- Written by Panaxia Pharmaceuticals Industries
Joint venture between Ultra Health, Panaxia brings smokeless cannabis medicine to United States
(Albuquerque, New Mexico) – Ultra Health®, New Mexico’s No. 1 cannabis company with a nationwide presence, and Panaxia Pharmaceuticals Industries Ltd, an Israeli pharmaceutical company specializing in pharmaceutical cannabis R&D and manufacturing, launched their first pharmaceutical cannabis production facility in the United States, located in Bernalillo, New Mexico. The facility will manufacture smokeless, accurately dosed cannabis medicine in a variety of delivery methods.
Panaxia is providing smokeless proprietary cannabinoid dosage and treatment protocols, which are not readily available in the United States, in order to manufacture state-of-the-art products to treat a number of illnesses. The production facility is implementing Panaxia's technology, including advanced Good Manufacturing Practice (GMP) production protocols as well as validated analytical system and proprietary production technology.
The smokeless products include sublingual and oral tablets, rectal and vaginal suppositories, cannabis oil, pastilles, transdermal pain relief patches and topical creams for the treatment of pain, burns and psoriasis. They are beneficial to current chronic conditions requiring ongoing dosing such as PTSD, chronic pain, cancer, neuropathy pain, epilepsy, anorexia and HIV/AIDS.
“The new 18 smokeless-designed cannabis products are providing better delivery systems for patients and physicians by delivery of a fully potent, targeted dosage specifically tailored to the patient’s needs,” said Duke Rodriguez, CEO and President of Ultra Health. “Patients will also have the opportunity to purchase products containing only Tetrahydrocannabinol (THC), products containing only Cannabidiol, (CBD) as well as products with an equal THC and Cannabidiol (CBD) ratio.”
"At Ultra Health, our mission is to provide superior-quality and affordable medical grade cannabis to New Mexico patient's,” Rodriguez said. “Ultra Health is driven by compassionate innovation and supported by science and technology. It is important that we develop new products in anticipation of meeting the rapidly growing patient and provider demands.”
"We are extremely excited to open our first production facility in the United States,” said Dr. Dadi Segal, CEO of Panaxia. “It is history in the making for an Israeli company to bring the tidings to the citizens of New Mexico. Panaxia is part of an organization that has been active in the Israeli and global pharmaceutical industry for more than 40 years. Since we established Panaxia in 2010, we constantly strive to bring the strictest protocols and most advanced technology available in the pharma industry to the production of our cannabis based products. At Panaxia, we believe that pharmaceutical cannabis products should be developed and manufactured under the highest standards and quality assurance levels like any other pharmaceutical product. We are happy to move forward into bringing smokeless, exact and reproducible dosing capabilities for medical cannabis products to the United States market."
He continued: "We believe in the coming months of 2017 both companies will be launching an additional production".
About Ultra Health
Ultra Health is a turnkey solutions provider for the specialty healthcare cannabis industry, with operations and facilities in Arizona, New Mexico, and Nevada. From retail dispensaries to commercial-scale cannabis production, Ultra Health offers the unmatched technical expertise, proprietary business tools and deep industry knowledge to fulfill the specific requirements of any project related to the cannabis industry. Ultra Health partners with a broad spectrum of businesses and Tribal Nations to design formulate and manage cannabis-related economic development opportunities that are profitable, scalable and mutually beneficial.
About Panaxia pharmaceutical industries Ltd
Panaxia pharmaceutical Industries is a manufacturer of pharmaceutical dosage forms based on Cannabis. The company is part of a larger group of companies, which manufacture pharmaceuticals for more than 40 years. Altogether, the group produces more than 300 different conventional medication products, with a wide range of indications from sore throat lozenges to dermal fillers. The group sells in more than 25 countries and is very R&D oriented. Panaxia pharmaceutical Industries has been developing and manufacturing pharmaceutical products based on cannabis since 2010.
- Written by Rambam Health Care Campus
A new, cutting- edge technology that allows for complete medical information confidentiality was implemented at Rambam last week. The BIG DATA software enables physicians and researchers to conduct a wide range of searches quickly, all while maintaining patients' medical record confidentiality.
- Written by Cyber Security Conference
APERIO systems was recognized as the most innovative cyber security startup; The five finalists included Cybellum, Sepio Systems, Cymulate & Intezer The announcement was made during a special panel at Cybertech 2017, held in Israel for the fourth time at Pavilion 2 in the Israel Trade Fairs & Convention Center
Buky Carmeli, Head of the Israel National Cyber Security Authority, BG (res) Dr. Daniel Gold, Head of Defense R&D Directorate, IMOD/IDF & Head of Israel National Civilian R&D committee and other cyber security executives were among the prominent speakers at the conference
Tel Aviv, Israel - APERIO Systems was selected as the most innovative startup in cyber security at “The Cybertech Startup Competition powered by YL Ventures", that took place during Cybertech 2017. Yoav Lightersdorf founder of YL Ventures, awarded the winning prize to company founders Yevgeni Nogin and Michael Shalyt. Winning over dozens of other applicants, APERIO Systems secures critical control systems with a last line of defense against both internal and external cyber threats and malicious actors. APERIO Systems enables unprecedented resilience and operational integrity for critical infrastructure such as power plants, water and waste control, manufacturing, oil and gas, energy, transportation, pharma, and food and beverage. The company uses statistical physics and state-of-the-art machine learning techniques to detect operational data forgery attempts and reconstruct the true state of industrial control systems in real time. More information at www.aperio-systems.com
Finalists in the competition included Intezer, who developed a “Shazam” like technology for software, able to identify the name and manufacturer of any unknown file or code, be it secure software or malware. Cymulate- a platform for extended simulation of cyber-attacks, enabling multiple controlled cyber-attacks in the main attack channels simultaneously at any given time, & Cybellum who developed a technology that stops zero-days attacks in the initial and critical stage of the breach.
The startup competition distinguished panel of judges are leading executives from information protection companies, cybersecurity industries and technological corporations as well as partners of American VC funds. The judges included David Cross, Cloud Security Engineering Director, Google Security and Privacy organization, USA, Glenn Chisholm, CTO, Cylance, Jacques Benoski, Partner, USVP,Jay Leek,CISO, The Blackstone Group & Doug Russell, Managing Director & SVP of Strategy & Corporate Development, MassMutual Ventures (Link to the complete Judges list) .
APERIO Systems won two tickets to the prestigious RSA convention, the world's leading cyber conference, being held this coming February in San Francisco. This will be an incredible opportunity for an Israeli start up to attend the largest and most influential Cyber security conference in the world.
Conference highlights – Feb. 1st:
Speaking at the conference’s opening plenary on Feb 1st, BG (res) Dr. Daniel Gold, Head of Defense R&D Directorate, IMOD/IDF & Head of Israel National Civilian R&D committee, stated that: "Holistic approach and collaboration are essential to our ability to address cyber security issues". In his speech, Gold said that "Cyber-attacks will become more powerful & frequent in the near future, and that the same trends are predicted for Ransom ware, SCADA cyber-attacks and DDOS attacks. Cyber-attacks at large are expected to become increasingly malicious and hazardous, creating greater damage and lasting longer".
Gold reviewed the responsibilities of the Defense R&D Directorate, Israel Defense Authorities’ largest R&D organization, which include: Military R&D, production and manufacture, spaceships and satellites, UMV’s, intelligence, aerial defense systems, electro optics, electronic warfare cyber, smart weapons and munitions, sensors, SIGINT etc.
Gold announced that the Directorate he’s heading is working on a program to be submitted to the Government, which will position Israel as a world leader in the cyber arena. The project, lead in collaboration with Academia, focuses on current developments in the field: "The most important issues in Cyber defense are a pro-active approach for cyber-attacks, environmental awareness - knowing who’s behind the attacks and responding accordingly- and damage control. A Holistic view of the field and complete cooperation on all sides, including government officials, can advance the development of systems and techniques for Cyber defense.”
Buky Carmeli, Head of the Israel National Cyber Security Authority, spoke at Cybertech about the role of the NCSA: “Our aim is to ensure that every person in Israel will be able to use the computer and the cyber space safely and securely. The NCSA was founded a year ago with only a few workers. Today it employees 170 people in Tel Aviv and Beersheba, engaged in the broad field of cyber protection in the civil sector. In September last year NCSA established the National CERT already operating successfully these days."
Carmeli added: "A national scale cyber-attack is a national scale emergency just like a weather emergency situation or a terror attack. The results of an attack can be severe and require building roadblocks & calling-up a large number of people for reserve duty.” The NCSA is formulating regulations, instructions and orders on how to handle such situations and is also involved in the preparation of the Cyber Law.
Other interesting assessments were made by Jeffrey Berkowitz and Gerson Panitch, partners at Finnegan who warned Israeli companies that lack sufficient patent protection: “Your competitors are applying for patents in an effort to block you”. The Finnegan representatives explained that “The cyber market for the next four years is estimated at a trillion dollars. That’s a lot of money. In 2015 there were about -35 000 patents in Cyber. This is a huge amount. But, while American companies register thousands of patents a year, Israeli companies only register dozens. It's a huge difference. It shows that Israel is far behind in the patent world. This means that Israeli companies are in trouble because anyone can block their ability to sell on the global market. There’s a huge market for Cyber, but if you are not protected by a patent, you won’t have any protection from a lawsuit with competitors".
Cybertech 2017 Conference, was held in Israel for the fourth year at Pavilion 2 of the Israel Trade Fairs & Convention Center on January 30th - February 1st. It is considered the second largest conference and exhibition of cyber technologies in the world. Cybertech, bringing together leading investors, entrepreneurs and cyber companies, is consisted of a conference with prominent international speakers in the field of cyber security, as well as an exhibition hosting over 250 companies and 100 startups, presenting innovative problem-solving strategies and solutions to challenges relevant for a wide range of sectors.
Photo Credit: Gilad Kavalerchik